IL1B and Creutzfeldt Jacob disease: In addition, genetic ablation of NLRP3 did not demonstrate any significant changes in IL-1β levels at the terminal stages of CJD, which suggests that NLRP3 inflammasome does not play a significant role in its pathogenesis[21].